LENNOX GASTAUT SYNDROME
Clinical trials for LENNOX GASTAUT SYNDROME explained in plain language.
Never miss a new study
Get alerted when new LENNOX GASTAUT SYNDROME trials appear
Sign up with your email to follow new studies for LENNOX GASTAUT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain implant tested to tame severe seizures
Disease control OngoingThis study is testing the safety and early effectiveness of an implanted brain stimulation device for people with a severe form of epilepsy called Lennox-Gastaut Syndrome (LGS). The device, called the RNS System, is designed to detect and respond to abnormal brain activity to hel…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Special program keeps seizure medication available for patients
Disease control NO_LONGER_AVAILABLEThis program provided continued access to perampanel medication for people with epilepsy who had previously participated in related studies. It allowed patients to keep receiving their seizure medication until it became commercially available in their country. The program was des…
Matched conditions: LENNOX GASTAUT SYNDROME
Sponsor: Eisai Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Safety check: does a seizure drug harm the liver over time?
Disease control OngoingThis study aims to monitor the long-term safety of Epidiolex (cannabidiol), a prescription medication for severe seizure disorders. It will check if long-term use causes chronic liver injury or scarring in 154 participants who are already taking or starting the drug. The main goa…
Matched conditions: LENNOX GASTAUT SYNDROME
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC